Gene expression profiling unveils the temporal dynamics of CIGB-300-regulated transcriptome in AML cell lines

por Vázquez-Blomquist, Dania, Ramón, Ailyn C., Rosales, Mauro, Pérez, George V., Rosales, Ailenis, Palenzuela, Daniel, Perera, Yasser, Perea, Silvio E.
Publicado 2023

CIGB-300-Regulated Proteome Reveals Common and Tailored Response Patterns of AML Cells to CK2 Inhibition

por Rosales, Mauro, Rodríguez-Ulloa, Arielis, Pérez, George V., Besada, Vladimir, Soto, Thalia, Ramos, Yassel, González, Luis J., Zettl, Katharina, Wiśniewski, Jacek R., Yang, Ke, Perera, Yasser, Perea, Silvio E.
Publicado 2022

Phosphoproteomic Landscape of AML Cells Treated with the ATP-Competitive CK2 Inhibitor CX-4945

por Rosales, Mauro, Rodríguez-Ulloa, Arielis, Besada, Vladimir, Ramón, Ailyn C., Pérez, George V., Ramos, Yassel, Guirola, Osmany, González, Luis J., Zettl, Katharina, Wiśniewski, Jacek R., Perera, Yasser, Perea, Silvio E.
Publicado 2021

Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection

por Ramón, Ailyn C., Pérez, George V., Caballero, Evelin, Rosales, Mauro, Aguilar, Daylén, Vázquez-Blomquist, Dania, Ramos, Yassel, Rodríguez-Ulloa, Arielis, Falcón, Viviana, Rodríguez-Moltó, María Pilar, Yang, Ke, Perera, Yasser, Perea, Silvio E.
Publicado 2022

CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model

por Pérez, George V., Rosales, Mauro, Ramón, Ailyn C., Rodríguez-Ulloa, Arielis, Besada, Vladimir, González, Luis J., Aguilar, Daylen, Vázquez-Blomquist, Dania, Falcón, Viviana, Caballero, Evelin, Carvalho, Paulo C., Caldeira, Rodrigo Soares, Yang, Ke, Perera, Yasser, Perea, Silvio E.
Publicado 2022

Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300

por Rosales, Mauro, Pérez, George V., Ramón, Ailyn C., Cruz, Yiliam, Rodríguez-Ulloa, Arielis, Besada, Vladimir, Ramos, Yassel, Vázquez-Blomquist, Dania, Caballero, Evelin, Aguilar, Daylen, González, Luis J., Zettl, Katharina, Wiśniewski, Jacek R., Yang, Ke, Perera, Yasser, Perea, Silvio E.
Publicado 2021

Treatment with an Anti-CK2 Synthetic Peptide Improves Clinical Response in COVID-19 Patients with Pneumonia. A Randomized and Controlled Clinical Trial

por Cruz, Leticia R., Baladrón, Idania, Rittoles, Aliusha, Díaz, Pablo A., Valenzuela, Carmen, Santana, Raúl, Vázquez, Maria M., García, Ariadna, Chacón, Deyli, Thompson, Delvin, Perera, Gustavo, González, Ariel, Reyes, Rafael, Torres, Loida, Pérez, Jesus, Valido, Yania, Rodriguez, Ralysmay, Vázquez-Bloomquist, Dania M., Rosales, Mauro, Ramón, Ailyn C., Pérez, George V., Guillén, Gerardo, Muzio, Verena, Perera, Yasser, Perea, Silvio E.
Publicado 2020